Evidence map›Paper›PMID 38473421›Full record

ArticleCancers2024

Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid.

Hyung Kyung Kim, Eunkyung Han, Jeonghyo Lee, Kwangil Yim, Jamshid Abdul-Ghafar, Kyung Jin Seo, Jang Won Seo, Gyungyub Gong, Nam Hoon Cho, Milim Kim and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Hyung Kyung KimDepartment of Pathology, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.ORCID 0000-0003-0271-2493
Eunkyung HanDepartment of Pathology, Soonchunyang University Hospital Bucheon, Bucheon 14584, Republic of Korea.
Jeonghyo LeeDepartment of Pathology, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.ORCID 0000-0002-3523-921X
Kwangil YimDepartment of Hospital Pathology, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.ORCID 0000-0001-8767-9033
Jamshid Abdul-GhafarDepartment of Hospital Pathology, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.ORCID 0000-0002-6575-8870
Kyung Jin SeoDepartment of Hospital Pathology, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.ORCID 0000-0002-1908-9696
Jang Won SeoAI Team, MTS Company Inc., Seoul 06178, Republic of Korea.
Gyungyub GongDepartment of Pathology, Asan Medical Center, Seoul 05505, Republic of Korea.
Nam Hoon ChoDepartment of Pathology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Milim KimDepartment of Pathology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.ORCID 0000-0001-6966-1606
Chong Woo YooDepartment of Pathology, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0002-5221-4516
Yosep ChongDepartment of Hospital Pathology, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.ORCID 0000-0001-8615-3064
Catholic University of Korea · KRYonsei University · KRAsan Medical Center · KRBucheon University · KRNational Cancer Center · KRSamsung Medical Center · KRSeoul National University Bundang Hospital · KR

Funding

This work was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (2021R1A2C2013630) and grant no. 00-2022-0034 from the Seoul National University Bundang Hospital (SNUBH) Research Fund. (2021R1A2C2013630) and (00-2022-0034)
6 · The paper itself

Abstract

Ascites cytology is a cost-effective test for metastatic colorectal cancer (CRC) in the abdominal cavity. However, metastatic carcinoma of the peritoneum is difficult to diagnose based on biopsy findings, and ascitic aspiration cytology has a low sensitivity and specificity and a high inter-observer variability. The aim of the present study was to apply artificial intelligence (AI) to classify benign and malignant cells in ascites cytology patch images of metastatic CRC using a deep convolutional neural network. Datasets were collected from The OPEN AI Dataset Project, a nationwide cytology dataset for AI research. The numbers of patch images used for training, validation, and testing were 56,560, 7068, and 6534, respectively. We evaluated 1041 patch images of benign and metastatic CRC in the ascitic fluid to compare the performance of pathologists and an AI algorithm, and to examine whether the diagnostic accuracy of pathologists improved with the assistance of AI. This AI method showed an accuracy, a sensitivity, and a specificity of 93.74%, 87.76%, and 99.75%, respectively, for the differential diagnosis of malignant and benign ascites. The diagnostic accuracy and sensitivity of the pathologist with the assistance of the proposed AI method increased from 86.8% to 90.5% and from 73.3% to 79.3%, respectively. The proposed deep learning method may assist pathologists with different levels of experience in diagnosing metastatic CRC cells of ascites.

Indexed as

artificial intelligenceascites cytologycolorectal carcinomametastatic carcinoma

Identifiers

PMID38473421
PMCPMC10931097
OpenAlexW4392472304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.